公开(公告)号：US20230054073A1

公开(公告)日：2023-02-23

申请号：US17882671

申请日：2022-08-08

Applicant: NEUROQUEST LTD.

Inventor： Xin Huang ,  Yihan Li ,  Christopher Fowler ,  James Doecke ,  Colin L. Masters ,  Baijun Gu

IPC: G01N33/58 ,  C07K16/28 ,  G01N33/68

Abstract: Compositions and kits for diagnosing and prognosing Alzheimer's Disease (AD) in a human patient include a binding agent such as a monoclonal antibody for a biomarker conjugated to a detectable moiety such as a fluorophore, wherein the biomarker is chosen from CD163, CD91, CD59, MerTK and other phagocytosis-related molecules. Further compositions and kits employ panels of fluorophore-conjugated monoclonal antibodies for biomarkers including scavenger receptors. Methods for determining the relative expression of biomarkers, diagnosing AD, and determining the efficacy of AD therapeutic candidates such as phagocytosis-promoting agents and scavenger receptor agonists also appear.